Helicobacter infection
Conditions
Interventions
Tailored treatment Group(Clarithromycin):N/A
Classic Bismuth Quadruple Treatment Group:N/A
Dual Thrapy Group:N/A
Tailored treatment Group(Levofloxacin):N/A
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: Patients who visited our hospital for gastroscopy and colonoscopy 2: Positive UBT and gastroscopic mucosal biopsy suggesting positive Hp RUT 3: No previous treatment for Hp infection eradication 4: Age = 18 years 5: Voluntary participation and ability to cooperate with the study
Exclusion criteria
Exclusion criteria: 1: Drugs that may affect the study results, such as PPI, P-CAB, H2 receptor blockers, bismuth, antibiotics, etc., had been taken within four weeks before enrollment 2: Patients with gastrointestinal malignancies 3: Patients with gastrinoma 4: Patients with postoperative gastrointestinal or esophageal surgery 5: Patients with serious heart, lung, kidney, liver, hematological, neurological, endocrine, and psychiatric system diseases 6: Patients who are allergic to the drugs used in this study 7: Pregnant or breastfeeding women who have not planned to have a pregnancy in the past 1 year 8: Combination of other medical conditions that may increase the side effects of treatment 9: Patients who cannot give informed consent or cannot cooperate with the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ß-Diversity;a-Diversity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance;Eradication rate;Safety (incidence of adverse reactions); | — |
Countries
China
Contacts
Public ContactZhiqiang Song
Department of Gastroenterology, Peking University Third Hospital
Outcome results
None listed